|
|
||||||||


* Department of Human Oncology and Comprehensive Cancer Center and
Department of Pediatrics, University of Wisconsin, Madison, WI 53792; and
Department of Immunology, Weizmann Institute of Science, Rehovot, Israel
We have previously shown that macrophages (M
) can be activated by CD40 ligation to become cytotoxic against tumor cells in vitro. Here we show that treatment of mice with agonistic anti-CD40 mAb (anti-CD40) induced up-regulation of intracellular TLR9 in M
and primed them to respond to CpG-containing oligodeoxynucleotides (CpG), resulting in synergistic activation. The synergy between anti-CD40 and CpG was evidenced by increased production of IFN-
, IL-12, TNF-
, and NO by M
, as well as by augmented apoptogenic effects of M
against tumor cells in vitro. The activation of cytotoxic M
after anti-CD40 plus CpG treatment was dependent on IFN-
but not TNF-
or NO, and did not require T cells and NK cells. Anti-CD40 and CpG also synergized in vivo in retardation of tumor growth in both immunocompetent and immunodeficient mice. Inactivation of M
in SCID/beige mice by silica treatment abrogated the antitumor effect. Taken together, our results show that M
can be activated via CD40/TLR9 ligation to kill tumor cells in vitro and inhibit tumor growth in vivo even in immunocompromised tumor-bearing hosts, indicating that this M
-based immunotherapeutic strategy may be appropriate for clinical testing.
This article has been cited by other articles:
![]() |
H. Fujii, J. D. Trudeau, D. T. Teachey, J. D. Fish, S. A. Grupp, K. R. Schultz, and G. S. D. Reid In vivo control of acute lymphoblastic leukemia by immunostimulatory CpG oligonucleotides Blood, March 1, 2007; 109(5): 2008 - 2013. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Kornbluth and G. W. Stone Immunostimulatory combinations: designing the next generation of vaccine adjuvants J. Leukoc. Biol., November 1, 2006; 80(5): 1084 - 1102. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. D. Lum, I. N. Buhtoiarov, B. E. Schmidt, G. Berke, D. M. Paulnock, P. M. Sondel, and A. L. Rakhmilevich In vivo CD40 ligation can induce T cell-independent antitumor effects that involve macrophages J. Leukoc. Biol., June 1, 2006; 79(6): 1181 - 1192. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |